Two years ago, the 3-year results of the Ahmed Baerveldt Comparison (ABC) were released. For further follow-up, the study group is presenting the 5-year outcomes. A total of 276 patients initially ...

The US Food and Drug Administration (FDA) has approved an intracameral implant with 75 mcg of travoprost to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular ...

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...

Efficacy is higher for the Xen 45 gel stent implant as a standalone procedure than combined with cataract surgery. The Xen 45 gel stent implant provides effective, long-term treatment for open-angle ...

A landmark glaucoma surgery was performed at the Army Hospital using the Hydrus Microstent guided by intraoperative aqueous angiography. This technique enhances drainage in glaucoma patients, marking ...

While the Xen 45 gel stent implant showed beneficial long-term outcomes for the treatment of open-angle glaucoma, a substantial proportion of patients needed follow-up operations or bleb needling, ...

In case you missed it, Glaukos, a prominent player in the Microinvasive Glaucoma Surgery (MIGS) space completed a 15-year regulatory journey. The San Clemente, CA-based company won a nod from FDA for ...

Doctors at the Army Hospital (Research and Referral) have achieved a world first breakthrough in glaucoma surgery, ...

Glaucoma can silently damage your optic nerve, leading to irreversible vision loss. Learn the early signs, risk factors, and ...